Bucindolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Bucindolol
Bucindolol.png
Systematic (IUPAC) name
2-[2-hydroxy-3-[[2-(1H-indol-3-yl)-1,1-dimethyl-ethyl]amino]propoxy]benzonitrile
Identifiers
CAS Number 71119-11-4
ATC code none
PubChem CID 51045
ChemSpider 46266
UNII E9UO06K7CE YesY
ChEMBL CHEMBL2107546
Chemical data
Formula C22H25N3O2
Molar mass 363.45 g/mol

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity.[1][2] It was under review by the FDA in the United States for the treatment of heart failure in 2009, but was rejected due to issues pertaining to integrity of data submitted.[1][3]

See also[edit]

References[edit]